Works matching IS 2574173X AND DT 2023 AND VI 43 AND IP 3

Results: 22

Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia.

Published in:

Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 391, doi. 10.1002/npr2.12366

By:

Aoki, Yumi;
Takaesu, Yoshikazu;
Matsui, Kentaro;
Tokumasu, Takahiro;
Tani, Hideaki;
Takekita, Yoshiteru;
Kanazawa, Tetsufumi;
Kishimoto, Taishiro;
Tarutani, Seiichiro;
Hashimoto, Naoki;
Takeuchi, Hiroyoshi;
Mishima, Kazuo;
Inada, Ken

Publication type:

Article

Japanese Society of Anxiety and Related Disorders/Japanese Society of Neuropsychopharmacology: Clinical practice guideline for social anxiety disorder (2021).

Published in:

Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 288, doi. 10.1002/npr2.12365

By:

Asakura, Satoshi;
Yoshinaga, Naoki;
Yamada, Hisashi;
Fujii, Yutaka;
Mitsui, Nobuyuki;
Kanai, Yoshihiro;
Inoue, Takeshi;
Shimizu, Eiji

Publication type:

Article

Effects of age on suicide attempts by medication in patients transferred to the emergency rooms of two advanced medical centers: A retrospective chart review of the DJ project.

Published in:

Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 453, doi. 10.1002/npr2.12367

By:

Sasaki, Taro;
Shinozaki, Masataka;
Nemoto, Aki;
Nagao, Yukiko;
Yasuda, Manabu;
Shimoda, Kazutaka;
Suda, Shiro;
Yasui‐Furukori, Norio

Publication type:

Article

Effects of riluzole on psychiatric disorders with anxiety or fear as primary symptoms: A systematic review.

Published in:

Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 320, doi. 10.1002/npr2.12364

By:

Kawashima, Yoshitaka;
Yamada, Misa;
Furuie, Hiroki;
Kuniishi, Hiroshi;
Akagi, Kie;
Kawashima, Tomoko;
Noda, Takamasa;
Yamada, Mitsuhiko

Publication type:

Article

Item response theory analysis of the University Personality Inventory in medical students.

Published in:

Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 446, doi. 10.1002/npr2.12362

By:

Sugawara, Norio;
Yasui‐Furukori, Norio;
Sayama, Masayuki;
Shimoda, Kazutaka

Publication type:

Article

Differences in self‐reported psychotic symptoms between patients with autism spectrum disorder and those with schizophrenia.

Published in:

Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 457, doi. 10.1002/npr2.12374

By:

Yamada, Momoka;
Sugawara, Norio;
Kawamata, Yasushi;
Yasui‐Furukori, Norio

Publication type:

Article

Five‐year trend of antipsychotic prescription practices in a district Hospital in Ghana: A retrospective study.

Published in:

Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 434, doi. 10.1002/npr2.12372

By:

Daliri, Dennis Bomansang;
Afaya, Agani;
Laari, Timothy Tienbia;
Fredrick, Adiak;
Ankamah, Ama Gaynor;
Annan, Susana;
Abagye, Nancy

Publication type:

Article

Preventive effect of aripiprazole once monthly on rehospitalization for bipolar disorder: A multicenter 1‐year retrospective mirror image study.

Published in:

Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 425, doi. 10.1002/npr2.12371

By:

Goto, Junichi;
Shono, Masahiro;
Abe, Yasuhisa;
Fujita, Yasutaka;
Ueda, Keishi;
Yoshida, Binchi;
Nabeshima, Yoshihiro

Publication type:

Article

Inhibition of the dorsomedial striatal direct pathway is essential for the execution of action sequences.

Published in:

Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 414, doi. 10.1002/npr2.12369

By:

Kono, Anna;
Shikano, Yu;
Tanaka, Kenji F.;
Yamaura, Katsunori;
Tsutsui‐Kimura, Iku

Publication type:

Article

Lipid‐correlated alterations in the transcriptome are enriched in several specific pathways in the postmortem prefrontal cortex of Japanese patients with schizophrenia.

Published in:

Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 403, doi. 10.1002/npr2.12368

By:

Arihisa, Wataru;
Kondo, Takeshi;
Yamaguchi, Katsushi;
Matsumoto, Junya;
Nakanishi, Hiroki;
Kunii, Yasuto;
Akatsu, Hiroyasu;
Hino, Mizuki;
Hashizume, Yoshio;
Sato, Shumpei;
Sato, Shinji;
Niwa, Shin‐Ichi;
Yabe, Hirooki;
Sasaki, Takehiko;
Shigenobu, Shuji;
Setou, Mitsutoshi

Publication type:

Article

Expression and role of nicotinic acetylcholine receptors during midbrain dopaminergic neuron differentiation from human induced pluripotent stem cells.

Published in:

Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 440, doi. 10.1002/npr2.12361

By:

Kato, Takeshi;
Nishimura, Kaneyasu;
Hirao, Masahiro;
Shimohama, Shun;
Takata, Kazuyuki

Publication type:

Article

Pain‐focused psychological interventions in women with endometriosis: A systematic review.

Published in:

Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 310, doi. 10.1002/npr2.12348

By:

Samami, Elahe;
Shahhosseini, Zohreh;
Khani, Soghra;
Elyasi, Forouzan

Publication type:

Article

Association of two variable number of tandem repeats in the monoamine oxidase A gene promoter with suicide completion: The present study and meta‐analysis.

Published in:

Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 338, doi. 10.1002/npr2.12344

By:

Hasegawa, Masashi;
Tanifuji, Takaki;
Okazaki, Satoshi;
Otsuka, Ikuo;
Shirai, Toshiyuki;
Shindo, Ryota;
Horai, Tadasu;
Mouri, Kentaro;
Takahashi, Motonori;
Kondo, Takeshi;
Ueno, Yasuhiro;
Hishimoto, Akitoyo

Publication type:

Article

Case reports of two siblings with autism spectrum disorder and 15q13.3 deletions.

Published in:

2023

By:

Furukawa, Sawako;
Kushima, Itaru;
Aleksic, Branko;
Ozaki, Norio

Publication type:

Case Study

Effects of N‐acetylcysteine on oxidative stress biomarkers, depression, and anxiety symptoms in patients with multiple sclerosis.

Published in:

Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 382, doi. 10.1002/npr2.12360

By:

Khalatbari Mohseni, Golsa;
Hosseini, Seyed Ahmad;
Majdinasab, Nastaran;
Cheraghian, Bahman

Publication type:

Article

Pharmacokinetics, safety, and tolerability of single and multiple doses of zuranolone in Japanese and White healthy subjects: A phase 1 clinical trial.

Published in:

Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 346, doi. 10.1002/npr2.12359

By:

Sonoyama, Takuhiro;
Shimizu, Ryosuke;
Kubota, Ryuji;
Matsuo, Yumiko;
Okutsu, Daiki;
Yamanaka, Hideki;
Takasu, Keiko;
Ogawa, Koichi;
Motomiya, Tomoko

Publication type:

Article

Serum levels of high mobility group box‐1 protein (HMGB1) and soluble receptors of advanced glycation end‐products (RAGE) in depressed patients treated with electroconvulsive therapy.

Published in:

Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 359, doi. 10.1002/npr2.12358

By:

Abe, Hiromi;
Okada‐Tsuchioka, Mami;
Kajitani, Naoto;
Omori, Wataru;
Itagaki, Kei;
Shibasaki, Chiyo;
Boku, Shuken;
Matsuhisa, Tetsuaki;
Takebayashi, Minoru

Publication type:

Article

Longitudinal characteristics of insight and clinical factors in patients with schizophrenia.

Published in:

Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 373, doi. 10.1002/npr2.12356

By:

Sakai, Yoshie;
Ito, Satsuki;
Matsumoto, Junya;
Yasuda, Yuka;
Yamamori, Hidenaga;
Fujimoto, Michiko;
Hasegawa, Naomi;
Ishimaru, Keiichiro;
Miura, Kenichiro;
Hashimoto, Ryota

Publication type:

Article

Possible involvement of Interleukin‐17A in the deterioration of prepulse inhibition on acoustic startle response in mice.

Published in:

Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 365, doi. 10.1002/npr2.12351

By:

Wakabayashi, Chisato;
Kunugi, Hiroshi

Publication type:

Article

Withdrawal: [Miura A, Otani K, Miyai H, Fukushima H, Matsuishi K. Post‐acute COVID‐19 syndrome with severe sexually deviant behavior. Neuropsychopharmacol Rep. 2022].

Published in:: Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 467, doi. 10.1002/npr2.12343
Publication type:: Article

Long‐term safety and efficacy of sublingual asenapine for the treatment of schizophrenia: A phase III extension study with follow‐up for 52 weeks (P06125)—Secondary publication.

Published in:

Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 328, doi. 10.1002/npr2.12342

By:

Kinoshita, Toshihiko;
Takekita, Yoshiteru;
Hiraoka, Shuichi;
Tamura, Fumihiro;
Iwama, Yasuhiro

Publication type:

Article

Issue Information.

Published in:: Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 287, doi. 10.1002/npr2.12265
Publication type:: Article